• <table id="gigg0"></table>
  • west china medical publishers
    Keyword
    • Title
    • Author
    • Keyword
    • Abstract
    Advance search
    Advance search

    Search

    find Keyword "尿微量白蛋白" 3 results
    • The Relationship between Microalbuminuria and Coronary Artery Disease

      摘要:目的: 研究尿微量白蛋白與冠心病的相關性。 方法 : 按冠狀動脈造影診斷標準將116例患者分為冠心病組(82人) 與非冠心病組(34人),測定晨尿白蛋白/ 肌酐濃度值(ACR),比較兩組患者尿ACR 并分析ACR與冠脈病變程度的相關性。 結果 : 冠心病組ACR顯著高于非冠心病組的; ACR與冠脈計分呈顯著的直線正相關。 結論 :冠心病患者ACR水平升高,微量白蛋白尿與冠狀動脈病變范圍和程度密切相關, 且對冠狀動脈狹窄程度具有獨立預測價值。Abstract: Objective: To investigate the relationship between microalbuminuria and coronary artery disease(CAD). Methods : According to the diagnostic standard of coronary artery angiography,116 patients were divided into CAD group (82 patients) and nonCAD group (34 patients). The albumin and creatinine concentrationratio ratio(ACR) in morning urine samples from patients of both groups was estimated and compared. The correlation of ACR to the extent of coronary lesions was analyzed. Results : ACR in the CAD group was significantly higher than that in nonCAD group. A distinctly linear positive correlation existed between ACR and the score of the coronary lesions. Conclusion : ACR increase in patients with CHD.Micoalbuminuria was associated with the severity of coronary lesions in patients with CHD and is an independent predictor of CAD.

      Release date:2016-09-08 10:12 Export PDF Favorites Scan
    • 尿酸干預治療對高尿酸血癥合并糖尿病前期患者腎臟損害的影響

      目的探討尿酸干預治療對高尿酸血癥合并糖尿病前期患者腎臟損害的影響。 方法選擇2008年2月-2011年8月在院診治的男性無癥狀高尿酸血癥合并糖尿病前期患者50例,給予低嘌呤飲食聯合降尿酸藥物干預治療;隨訪1年,比較治療前后尿微尿白蛋白(MAU)、血清胱抑素C(CysC)、尿酸和空腹血糖(FPG)。 結果治療前后尿酸分別為(509.40±36.00)、(340.00±39.00)μmol/L,FPG分別為(6.78±0.21)、(5.75±0.65)mmol/L,MAU分別為(45.60±18.30)、(26.30±10.50)mg/L,CysC分別為(1.36±0.15)、(0.89±0.33)mg/L,治療后各指標均較治療前降低,差異有統計學意義(P<0.05)。 結論血尿酸干預治療可降低高尿酸血癥合并糖尿病前期患者的腎臟損害,并可降低其FPG水平。

      Release date:2016-10-02 04:54 Export PDF Favorites Scan
    • Predictive value of serum cystatin C in sight-threatening diabetic retinopathy

      ObjectiveTo observe and evaluate the predictive value of serum cystatin C (Cys-C) on the risk of sight-threatening diabetic retinopathy (STDR). MethodsA non-randomized controlled cross-sectional clinical study. Ninety-two patients with type 2 diabetes mellitus (T2DM) who were admitted to Department of Ophthalmology of Beijing Tsinghua Changgung Hospital from January 2022 to October 2022 were included in the study. Among them, 50 were male, 42 cases were female, with the mean age of (58.24±12.49) years. The mean duration of T2DM was (13.18±8.35) years, of which 38 cases had a duration of ≥10 years. Twenty-nine cases complicated with hypertension, of which 16 cases had a duration of ≥10 years. Seventeen cases complicated with chronic kidney disease stage 2 and 23 cases were treated with lipid-lowering drugs. Hemoglobin Alc, serum Cys-C, serum lipids and renal function were tested, and urinary microalbumin/creatinine ratio (ACR) was calculated. According to the 2003 American Academy of Ophthalmology "Clinical Guidelines for Diabetic Retinopathy (DR)" and international clinical DR severity grading standards, the patients were divided into STDR and non-STDR groups, with 44 and 48 cases in each group, respectively. STDR was defined as severe non-proliferative DR, proliferative DR, and macular edema. Logistic regression was used to analyze the independent risk factors of STDR in T2DM patients. Receiver operating characteristic curve (ROC curve) was used to calculate and analyze the area under ROC curve (AUC) and the predictive value of serum Cys-C and ACR in predicting STDR in T2DM patients. ResultsSerum Cys-C levels in STDR and non-STDR groups were 1.10 (0.94, 1.28) and 0.91 (0.83, 1.02) mg/L, respectively, with ACR of 4.29 (1.05, 21.89) and 1.39 (0.77, 3.80) mg/mmol, respectively. Compared with non-STDR group, serum Cys-C and ACR in STDR group were higher, and the difference was statistically significant (Z=-3.984, -3.280; P<0.05). Multivariate logistic regression analysis showed that serum Cys-C was an independent risk factor for STDR (odds ratio=1.337, 95% confidence interval 1.145-2.090, P=0.033), and the risk of STDR increased by 33.7% for every 0.1 mg/L increase in serum Cys-C. ROC analysis results showed that serum Cys-C>1.065 mg/L combined with ACR>5.84 mg/mmol predicted the AUC of STDR in T2DM patients was 0.661, with the specificity of 95.8%. ConclusionsThe high serum Cys-C level is an independent risk factor for STDR in T2DM patients. Serum Cys-C has high predictive value for the occurrence of STDR.

      Release date:2024-09-20 10:48 Export PDF Favorites Scan
    1 pages Previous 1 Next

    Format

    Content

  • <table id="gigg0"></table>
  • 松坂南